# Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)

> **NCT04861103** · PHASE4 · RECRUITING · sponsor: **University of California, Irvine** · enrollment: 12 (estimated)

## Conditions studied

- Pregnancy, High Risk
- Anticoagulants

## Interventions

- **DRUG:** Lovenox

## Key facts

- **NCT ID:** NCT04861103
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-10-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04861103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04861103, "Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04861103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*